Literature DB >> 12110026

Vascular access and increased risk of death among hemodialysis patients.

Stephen Pastan1, J Michael Soucie, William M McClellan.   

Abstract

BACKGROUND: Hemodialysis with a venous catheter increases the risk of infection. The extent to which venous catheters are associated with an increased risk of death among hemodialysis patients has not been extensively studied.
METHODS: We conducted a retrospective cohort study of 7497 prevalent hemodialysis patients to assess the association between dialysis with a venous catheter and risk of death due to all causes and to infection.
RESULTS: A tunneled cuffed catheter was used for access in 12% of the patients and non-cuffed, not tunneled catheter in 2%. Younger age (P = 0.0005), black race (P = 0.0022), female gender (P = 0.0004), short duration since starting dialysis (P = 0.0003) and impaired functional status (P = 0.0001) were independently associated with increased use of catheter access. The proportion of patients who died was higher among those who were dialyzed with a non-cuffed (16.8%) or cuffed (15.2%) catheter compared to those dialyzed with either a graft (9.1%) or a fistula (7.3%; P < 0.001). The proportion of deaths due to infection was higher among patients dialyzed with a catheter (3.4%) compared to those dialyzed with either a graft (1.2%) or a fistula (0.8%; P < 0.001). The adjusted odds ratio (95% CI) for all-cause and infection-related death among patients dialyzed with a catheter was 1.4 (1.1, 1.9) and 3.0 (1.4, 6.6), respectively, compared to those with an arteriovenous (AV) fistula.
CONCLUSION: Venous catheters are associated with an increased risk of all-cause and infection-related mortality among hemodialysis patients.

Entities:  

Mesh:

Year:  2002        PMID: 12110026     DOI: 10.1046/j.1523-1755.2002.00460.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  87 in total

1.  The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.

Authors:  Krishna Poinen; Robert R Quinn; Matthew J Oliver; Daniel Devoe; Rameez Kabani; Fareed Kamar; Priyanka Mysore; Adriane M Lewin; Swapnil Hiremath; Jennifer MacRae; Matthew T James; Lisa Miller; Brenda R Hemmelgarn; Louise M Moist; Amit X Garg; Tanvir T Chowdhury; Pietro Ravani
Journal:  J Am Soc Nephrol       Date:  2016-10-06       Impact factor: 10.121

2.  Risk of catheter-related bloodstream infection in elderly patients on hemodialysis.

Authors:  Mariana Murea; Kimone M James; Greg B Russell; Graham V Byrum; James E Yates; Nicholas S Tuttle; Anthony J Bleyer; John M Burkart; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

3.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

4.  Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Authors:  Tanushree Banerjee; S Joseph Kim; Brad Astor; Tariq Shafi; Josef Coresh; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2014-09-27       Impact factor: 8.860

5.  Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis.

Authors:  Kevin F Erickson; Matthew Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

6.  Comorbidities do not influence primary fistula success in incident hemodialysis patients: a prospective study.

Authors:  Wenjie Wang; Brendan Murphy; Serdar Yilmaz; Marcello Tonelli; Jennifer Macrae; Braden J Manns
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

7.  Predictors of central venous catheter use at the initiation of hemodialysis.

Authors:  Haimanot Wasse; Rebecca A Speckman; Diane L Frankenfield; Michael V Rocco; William M McClellan
Journal:  Semin Dial       Date:  2008-06-28       Impact factor: 3.455

Review 8.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

9.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388

10.  Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.

Authors:  Jennifer K Broom; Stacey O'Shea; Sridevi Govindarajulu; E Geoffrey Playford; Carmel M Hawley; Nicole M Isbel; Scott B Campbell; David W Mudge; Sally Carpenter; Barbara C Johnson; Neil P Underwood; David W Johnson
Journal:  BMC Nephrol       Date:  2009-08-20       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.